Disc Medicine, Inc.·4

Apr 15, 4:53 PM ET

Franchi Jean M. 4

4 · Disc Medicine, Inc. · Filed Apr 15, 2026

Research Summary

AI-generated summary of this filing

Updated

Disc Medicine (IRON) CFO Jean M. Franchi Sells Shares

What Happened
Jean M. Franchi, Chief Financial Officer of Disc Medicine (IRON), sold a total of 6,657 shares in open-market transactions on April 13–14, 2026, for aggregate proceeds of roughly $460,834. Breakdown: 400 shares sold on 2026-04-13 at $69.00 each ($27,600) and 6,257 shares sold on 2026-04-14 at a weighted average price of $69.24 ($433,234). These were sales (not purchases), which are commonly routine dispositions.

Key Details

  • Transaction dates and prices:
    • 2026-04-13: 400 shares sold at $69.00 — $27,600
    • 2026-04-14: 6,257 shares sold at a weighted avg $69.24 — $433,234 (reported price range $69.07–$69.43)
  • Total shares sold: 6,657; total proceeds: ~$460,834
  • Filing: Form 4 filed 2026-04-15 (timely relative to the reported transactions)
  • Shares owned after transaction: Not disclosed in the provided Form 4 excerpt
  • Footnotes:
    • Trades were effected pursuant to a Rule 10b5-1 trading plan adopted September 25, 2025 (F1)
    • The 4/14 price is a weighted average; the filer can provide a per-price breakdown on request (F2)

Context
These sales were executed under a pre-established 10b5-1 plan, which is a common mechanism for insiders to schedule trades. Sales do not necessarily indicate a change in outlook; purchases tend to be more indicative of insider confidence. No indication of option exercises, gifts, or tax-withholding in this filing excerpt.

Insider Transaction Report

Form 4
Period: 2026-04-13
Franchi Jean M.
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    [F1]
    2026-04-13$69.00/sh400$27,60070,590 total
  • Sale

    Common Stock

    [F1][F2]
    2026-04-14$69.24/sh6,257$433,23464,333 total
Footnotes (2)
  • [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on September 25, 2025.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.07 to $69.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Signature
By: /s/ Rahul Khara, as Attorney-in-Fact|2026-04-15

Documents

1 file
  • 4
    ownership.xmlPrimary

    4